Skip to main content

Table 3 EOS end of study, EOF end of follow-up

From: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial

Visit

Basal and randomization, day 0

Day 3 ± 1

Day 12 ± 2

 

V#1

V#2

V#3

EOS

EOF

Informed consent

X

Inclusion/exclusion criteria

X

Demographic data and medical history

X

Concomitant medication

X

Vital signs*

X

X

Anthropometric data^

X

Basal laboratory

X

PCR swab

X

X

Assessment of adverse events

X

X

X

Final objective evaluation

X

X

X

X

Randomization

X

Adherence to treatment

X

X

  1. *Includes heart rate, temperature, and oxygen saturation by a digital saturometer
  2. ^Includes weight and height